• Chambers DC, Cherikh WS, Harhay MO, Hayes D, Hsich E, Khush KK, et al. The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1042–55. https://doi.org/10.1016/j.healun.2019.08.001. Most recent update to ISHLT registry data describing short- and long-term outcomes in lung transplant recipients, burden of post-transplant malignancy.
Kozower BD, Meyers BF, Smith MA, De Oliveira NC, Cassivi SD, Guthrie TJ, et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg. 2008;135(1):166–71. https://doi.org/10.1016/j.jtcvs.2007.08.044.
Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States. J Heart Lung Transplant. 2016;35(4):433–9. https://doi.org/10.1016/j.healun.2016.01.010.
Ranganath NK, Malas J, Phillips KG, Lesko MB, Smith DE, Angel LF, et al. Single and double lung transplantation have equivalent survival for idiopathic pulmonary fibrosis. Ann Thorac Surg. 2020;109(1):211–7. https://doi.org/10.1016/j.athoracsur.2019.06.090.
Chauhan D, Karanam AB, Merlo A, Tom Bozzay PA, Zucker MJ, Seethamraju H, et al. Post-transplant survival in idiopathic pulmonary fibrosis patients concurrently listed for single and double lung transplantation. J Heart Lung Transplant. 2016;35(5):657–60. https://doi.org/10.1016/j.healun.2015.12.030.
Li D, Liu Y, Wang B. Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. PLoS ONE. 2020;15(5):e0233732. https://doi.org/10.1371/journal.pone.0233732.
Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007;67(8):1167–98. https://doi.org/10.2165/00003495-200767080-00006.
Magruder JT, Crawford TC, Grimm JC, Kim B, Shah AS, Bush EL, et al. Risk factors for de novo malignancy following lung transplantation. Am J Transplant. 2017;17(1):227–38. https://doi.org/10.1111/ajt.13925.
Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med. 2007;101(12):2534–40. https://doi.org/10.1016/j.rmed.2007.07.012.
Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–6. https://doi.org/10.1183/09031936.00144208.
Kwak N, Park CM, Lee J, Park YS, Lee SM, Yim JJ, et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med. 2014;108(3):524–30. https://doi.org/10.1016/j.rmed.2013.11.013.
Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, et al. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging. 2014;41(2):337–42. https://doi.org/10.1007/s00259-013-2514-8.
Umeda Y, Demura Y, Morikawa M, Anzai M, Kadowaki M, Ameshima S, et al. Prognostic value of dual-time-point 18F-FDG PET for idiopathic pulmonary fibrosis. J Nucl Med. 2015;56(12):1869–75. https://doi.org/10.2967/jnumed.115.163360.
Strollo DC, Dacic S, Ocak I, Pilewski J, Bermudez C, Crespo MM. Malignancies incidentally detected at lung transplantation: radiologic and pathologic features. AJR Am J Roentgenol. 2013;201(1):108–16. https://doi.org/10.2214/AJR.12.9374.
Nakajima T, Cypel M, de Perrot M, Pierre A, Waddell T, Singer L, et al. Retrospective analysis of lung transplant recipients found to have unexpected lung cancer in explanted lungs. Semin Thorac Cardiovasc Surg. 2015;27(1):9–14. https://doi.org/10.1053/j.semtcvs.2015.02.006.
Klikovits T, Lambers C, Ghanim B, Dome B, Murakoezy G, Zöchbauer-Müller S, et al. Lung transplantation in patients with incidental early stage lung cancer-institutional experience of a high volume center. Clin Transplant. 2016;30(8):912–7. https://doi.org/10.1111/ctr.12764.
Panchabhai TS, Arrossi AV, Patil PD, Bandyopadhyay D, Budev MM, McCurry KR, et al. Unexpected neoplasms in lungs explanted from lung transplant recipients: a single-center experience and review of literature. Transplant Proc. 2018;50(1):234–40. https://doi.org/10.1016/j.transproceed.2017.12.024.
•• Ahmad U, Hakim AH, Tang A, Tong MZ, Bribriesco A, Budev M, et al. Patterns of recurrence and overall survival in incidental lung cancer in explanted lungs. Ann Thorac Surg. 2019;107(3):891–6. https://doi.org/10.1016/j.athoracsur.2018.09.022. Description of stage at diagnosis and outcomes for explant malignancy in large-single center cohort with high rates of disease recurrence (28%) within 2 years following transplant.
Grewal AS, Padera RF, Boukedes S, Divo M, Rosas IO, Camp PC, et al. Prevalence and outcome of lung cancer in lung transplant recipients. Respir Med. 2015;109(3):427–33. https://doi.org/10.1016/j.rmed.2014.12.013.
•• Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021;40(11):1349–79. https://doi.org/10.1016/j.healun.2021.07.005. Recently updated guidelines for candidate selection for lung transplantation highlighting considerations when evaluating patients with pre-transplant malignancy.
Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6(5):1507–13. https://doi.org/10.3892/ol.2013.1566.
Vadnerkar A, Toyoda Y, Crespo M, Pilewski J, Mitsani D, Kwak EJ, et al. Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant. 2011;30(3):273–81. https://doi.org/10.1016/j.healun.2010.08.032.
Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes D, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40(10):1060–72. https://doi.org/10.1016/j.healun.2021.07.021.
Courtwright A, Cantu E. Lung transplantation in elderly patients. J Thorac Dis. 2017;9(9):3346–51. https://doi.org/10.21037/jtd.2017.08.31.
•• Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, et al. Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement. Am J Transplant. 2021;21(2):460–74. https://doi.org/10.1111/ajt.16318. Consensus statement detailing pre-transplant cancer diagnosis, staging, and recommended disease-free intervals for candidates with prior solid organ tumors.
• Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, et al. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement. Am J Transplant. 2021;21(2):475–83. https://doi.org/10.1111/ajt.16324. Consensus statement detailing pre-transplant hematologic malignancy diagnosis, staging, and recommended disease-free intervals for candidates with prior hematologic malignancies or metastatic melanoma.
Acuna SA, Lam W, Daly C, Kim SJ, Baxter NN. Cancer evaluation in the assessment of solid organ transplant candidates: a systematic review of clinical practice guidelines. Transplant Rev (Orlando). 2018;32(1):29–35. https://doi.org/10.1016/j.trre.2017.10.002.
Paloyan EB, Swinnen LJ, Montoya A, Lonchyna V, Sullivan HJ, Garrity E. Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs. Transplantation. 2000;69(11):2446–8. https://doi.org/10.1097/00007890-200006150-00041.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85. https://doi.org/10.1097/JTO.0b013e318206a221.
Zorn GL, McGiffin DC, Young KR, Alexander CB, Weill D, Kirklin JK. Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 2003;125(1):45–8. https://doi.org/10.1067/mtc.2003.72.
de Perrot M, Chernenko S, Waddell TK, Shargall Y, Pierre AF, Hutcheon M, et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease. J Clin Oncol. 2004;22(21):4351–6. https://doi.org/10.1200/JCO.2004.12.188.
Garver RI, Zorn GL, Wu X, McGiffin DC, Young KR, Pinkard NB. Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl J Med. 1999;340(14):1071–4. https://doi.org/10.1056/NEJM199904083401403.
Ahmad U, Wang Z, Bryant AS, Kim AW, Kukreja J, Mason DP, et al. Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg. 2012;94(3):935–41. https://doi.org/10.1016/j.athoracsur.2012.04.069.
• Triplette M, Crothers K, Mahale P, Yanik EL, Valapour M, Lynch CF, et al. Risk of lung cancer in lung transplant recipients in the United States. Am J Transplant. 2019;19(5):1478–90. https://doi.org/10.1111/ajt.15181. Comparison of the characteristics and outcomes of lung cancer in lung transplant recipents compared with the general population.
Schulman LL, Htun T, Staniloae C, McGregor CC, Austin JH. Pulmonary nodules and masses after lung and heart-lung transplantation. J Thorac Imaging. 2000;15(3):173–9. https://doi.org/10.1097/00005382-200007000-00004.
Collins J, Kazerooni EA, Lacomis J, McAdams HP, Leung AN, Shiau M, et al. Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings. Radiology. 2002;224(1):131–8. https://doi.org/10.1148/radiol.2241011189.
Pérez-Callejo D, Torrente M, Parejo C, Laporta R, Ussetti P, Provencio M. Lung cancer in lung transplantation: incidence and outcome. Postgrad Med J. 2018;94(1107):15–9. https://doi.org/10.1136/postgradmedj-2017-134868.
Yserbyt J, Verleden GM, Dupont LJ, Van Raemdonck DE, Dooms C. Bronchial carcinoma after lung transplantation: a single-center experience. J Heart Lung Transplant. 2012;31(6):585–90. https://doi.org/10.1016/j.healun.2012.02.022.
• Chambers DC, Zuckermann A, Cherikh WS, Harhay MO, Hayes D, Hsich E, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics. J Heart Lung Transplant. 2020;39(10):1016–27. https://doi.org/10.1016/j.healun.2020.07.009. Recent ISHLT registry data describing outcomes of transplant of lungs from donors with known cancer risk factors such as tobacco and other recreational substance use, advancing age.
Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant. 2006;25(11):1297–301. https://doi.org/10.1016/j.healun.2006.09.009.
Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax. 1980;35(7):496–9. https://doi.org/10.1136/thx.35.7.496.
Kataoka T, Okudela K, Matsumura M, Baba T, Kitamura H, Arai H, et al. Significant accumulation of Oncol Lett. 2022;24(1):225. https://doi.org/10.3892/ol.2022.13346.
Comments (0)